Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningioma, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03015701
What this trial is testing

S9005 Mifepristone in Meningioma

Who this might be right for
Meningioma
SWOG Cancer Research Network 193
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT07411690
What this trial is testing

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

Who this might be right for
Brain Tumor AdultBrain Tumor BenignCerebroSpinal Fluid (CSF) Leak+4 more
Medical University of Warsaw 200
Early research (Phase 1)UnknownNCT02084927
What this trial is testing

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

Who this might be right for
Intracranial MeningiomaNeurologic Deficits
Assaf-Harofeh Medical Center 62
Not applicableUnknownNCT06278103
What this trial is testing

Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M)

Who this might be right for
Meningioma
Central Hospital, Nancy, France 180
Not applicableLooking for participantsNCT06557512
What this trial is testing

Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

Who this might be right for
MeningiomaMeningioma, MalignantRecurrent Meningioma
University of California, San Francisco 23
Not applicableLooking for participantsNCT06831461
What this trial is testing

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

Who this might be right for
Primary Brain TumorsDiffuse GliomaMeningioma+2 more
Tata Memorial Centre 156
Not applicableUnknownNCT02939833
What this trial is testing

Effects of Scalp Nerve Blocks on Systemic Inflammation

Who this might be right for
Meningiomas
RenJi Hospital 160
Testing effectiveness (Phase 2)Looking for participantsNCT06955169
What this trial is testing

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Who this might be right for
Intracranial Meningioma
RTOG Foundation, Inc. 130
Testing effectiveness (Phase 2)UnknownNCT06684795
What this trial is testing

FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery

Who this might be right for
Low-grade GliomaMeningiomaGlioma
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)Looking for participantsNCT06326190
What this trial is testing

177Lu-DOTATATE for Recurrent Meningioma

Who this might be right for
Recurrent Meningioma
European Organisation for Research and Treatment of Cancer - EORTC 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT03220646
What this trial is testing

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Who this might be right for
Brain Tumor
Memorial Sloan Kettering Cancer Center 64
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Not applicableWithdrawnNCT00985036
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Who this might be right for
GliomaMeningioma
Marquette General Health System
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Very early researchNot Yet RecruitingNCT07172178
What this trial is testing

Γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma

Who this might be right for
Malignant Meningioma
Nanjing Medical University 12
Not applicableWithdrawnNCT00005790
What this trial is testing

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Next Page